Screener
Revolution Medicines, Inc. RVMD Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s current ratio?
- Revolution Medicines, Inc. (RVMD) reported current ratio of 6.8× in Q1 2026.
- How has Revolution Medicines, Inc.'s current ratio changed year-over-year?
- Revolution Medicines, Inc.'s current ratio decreased by 49.5% year-over-year, from 13.5× to 6.8×.
- What is the long-term trend for Revolution Medicines, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s current ratio has grown at a -5.8% compound annual growth rate (CAGR), from 9.6× to 7.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Revolution Medicines, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude